Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Equity Average (2016 - 2026)

Orthofix Medical has reported Equity Average over the past 16 years, most recently at $442.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Equity Average fell 7.93% year-over-year to $442.6 million, compared with a TTM value of $442.6 million through Mar 2026, down 7.93%, and an annual FY2025 reading of $476.6 million, down 13.49% over the prior year.
  • Equity Average came in at $442.6 million for Q1 2026, down from $446.3 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $652.1 million in Q2 2023 to a low of $335.2 million in Q4 2022.
  • Median Equity Average over the past 5 years was $480.7 million (2025), compared with a mean of $482.8 million.
  • The sharpest move saw Equity Average surged 92.49% in 2023, then dropped 17.89% in 2025.
  • Over 5 years, Equity Average stood at $335.2 million in 2022, then skyrocketed by 81.12% to $607.1 million in 2023, then fell by 15.25% to $514.5 million in 2024, then dropped by 13.27% to $446.3 million in 2025, then dropped by 0.82% to $442.6 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Equity Average are $442.6 million (Q1 2026), $446.3 million (Q4 2025), and $450.4 million (Q3 2025).